Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Mar 21, 2008; 14(11): 1670-1681
Published online Mar 21, 2008. doi: 10.3748/wjg.14.1670
Published online Mar 21, 2008. doi: 10.3748/wjg.14.1670
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
Patrick Arbuthnot, Liam Jed Thompson, Antiviral Gene Therapy Research Unit, Department of Molecular Medicine and Haematology, University of the Witwatersrand Medical School, Private Bag 3, WITS 2050, South Africa
Author contributions: Arbuthnot PB and Thompson LJ wrote this paper, with Arbuthnot PB concentration on RNAi and Thompson LJ concentrating on HBV.
Correspondence to: Patrick Arbuthnot, Antiviral Gene Therapy Research Unit, Department of Molecular Medicine and Haema-tology, University of the Witwatersrand Medical School, Private Bag 3, WITS 2050, South Africa. patrick.arbuthnot@wits.ac.za
Telephone: +27-11-7172365
Fax: +27-11-7172395
Received: December 4, 2007
Revised: January 27, 2008
Published online: March 21, 2008
Revised: January 27, 2008
Published online: March 21, 2008
Core Tip